CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-09-30 | Wenstrup Richard Chief Medical Officer | Returned to the company | −931 | $20.58 | $19K | 50,207 |
| 2016-09-17 | Wenstrup Richard Chief Medical Officer | Returned to the company | −931 | $20.92 | $19K | 51,138 |
| 2016-09-14 | Wenstrup Richard Chief Medical Officer | Grant or award | +30,000 | 52,069 | ||
| 2015-09-17 | Wenstrup Richard Chief Medical Officer | Shares withheld for taxes | −931 | $41.39 | $39K | 22,069 |
| 2015-09-15 | Wenstrup Richard Chief Medical Officer | Grant or award | +11,500 | 23,000 |
Page 1 of 1 · 5 trades